Burden of Readmissions Among Patients With Critical Limb Ischemia

被引:40
作者
Agarwal, Shikhar [1 ]
Pitcavage, James M. [2 ]
Sud, Karan [3 ]
Thakkar, Badal [4 ]
机构
[1] Geisinger Med Ctr, Dept Cardiol, Sect Intervent Cardiol, 100 North Acad Ave, Danville, PA 17822 USA
[2] Inst Adv Applicat Geisinger Hlth Syst, Danville, PA USA
[3] Mt Sinai St Lukes Hosp, Dept Internal Med, New York, NY USA
[4] Rutgers New Jersey Med Sch, Dept Internal Med, Newark, NJ USA
关键词
critical limb ischemia; length of stay; mortality; readmissions; travel time; PERIPHERAL ARTERIAL-DISEASE; LOWER-EXTREMITY AMPUTATION; UNPLANNED READMISSION; REHOSPITALIZATION; OUTCOMES; BYPASS; MORTALITY; DISTANCE; GENDER; LENGTH;
D O I
10.1016/j.jacc.2017.02.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Readmissions constitute a major health care burden among critical limb ischemia (CLI) patients. OBJECTIVES This study aimed to determine the incidence of readmission and factors affecting readmission in CLI patients. METHODS All adult hospitalizations with a diagnosis code for CLI were included from State Inpatient Databases from Florida (2009 to 2013), New York (2010 to 2013), and California (2009 to 2011). Data were merged with the directory available from the American Hospital Association to obtain detailed information on hospital-related characteristics. Geographic and routing analysis was performed to evaluate the effect of travel time to the hospital on readmission rate. RESULTS Overall, 695,782 admissions from 212,241 patients were analyzed. Of these, 284,189 were admissions with a principal diagnosis of CLI (primary CLI admissions). All-cause readmission rates at 30 days and 6 months were 27.1% and 56.6%, respectively. The majority of these were unplanned readmissions. Unplanned readmission rates at 30 days and 6 months were 23.6% and 47.7%, respectively. The major predictors of 6-month unplanned readmissions included age, female sex, black/Hispanic race, prior amputation, Charlson comorbidity index, and need for home health care or rehabilitation facility upon discharge. Patients covered by private insurance were least likely to have a readmission compared with Medicaid/no insurance and Medicare populations. Travel time to the hospital was inversely associated with 6-month unplanned readmission rates. There was a significant interaction between travel time and major amputation as well as travel time and revascularization strategy; however, the inverse association between travel time and unplanned readmission rate was evident in all subgroups. Furthermore, length of stay during index hospitalization was directly associated with the likelihood of 6-month unplanned readmission (odds ratio for log-transformed length of stay: 2.39 [ 99% confidence interval: 2.31 to 2.47]). CONCLUSIONS Readmission among patients with CLI is high, the majority of them being unplanned readmissions. Several demographic, clinical, and socioeconomic factors play important roles in predicting readmissions. (J Am Coll Cardiol 2017; 69: 1897-908) (C) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:1897 / 1908
页数:12
相关论文
共 50 条
  • [1] Readmissions for Critical Limb Ischemia
    Shishehbor, Mehdi H.
    Aronow, Herbert D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (15) : 1909 - 1912
  • [2] Sex Differences in Trends and In-Hospital Outcomes Among Patients With Critical Limb Ischemia: A Nationwide Analysis
    Elbadawi, Ayman
    Barssoum, Kirolos
    Megaly, Michael
    Rai, Devesh
    Elsherbeeny, Ahmed
    Mansoor, Hend
    Shishehbor, Mehdi H.
    Abdel-Latif, Ahmed
    Gulati, Martha
    Elgendy, Islam Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (18):
  • [3] A nationwide analysis of 30-day readmissions related to critical limb ischemia
    Masoomi, Reza
    Shah, Zubair
    Quint, Clay
    Hance, Kirk
    Vamanan, Karthik
    Prasad, Anand
    Hoel, Andrew
    Dawn, Buddhadeb
    Gupta, Kamal
    VASCULAR, 2018, 26 (03) : 239 - 249
  • [4] A mortality prediction model for elderly patients with critical limb ischemia
    Roijers, Joost P.
    Rakke, Yannick S.
    Hopmans, Cornelis J.
    Buimer, Mathijs G.
    Ho, Gwan H.
    de Groot, Hans G. W.
    Veen, Eelco J.
    Mulder, Paul G. H.
    van der Laan, Lijckle
    JOURNAL OF VASCULAR SURGERY, 2020, 71 (06) : 2065 - +
  • [5] Contribution of prostaglandin E1 treatment in patients with critical limb ischemia
    Gaspar, Ludovit
    Komornikova, Andrea
    Kruzliak, Peter
    Rodrigo, Luis
    Gabbasov, Zufar
    Staffa, Robert
    Berezin, Alexander
    Gavornik, Peter
    Dukat, Andrej
    Ambrozy, Ewald
    Bendzala, Matej
    Sabaka, Peter
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3227 - 3231
  • [6] Efficacy of Revascularization for Critical Limb Ischemia in Patients with End-stage Renal Disease
    Yamamoto, S.
    Hosaka, A.
    Okamoto, H.
    Shigematsu, K.
    Miyata, T.
    Watanabe, T.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (03) : 316 - 324
  • [7] The burden of critical limb ischemia: a review of recent literature
    Duff, Steve
    Mafilios, Michael S.
    Bhounsule, Prajakta
    Hasegawa, James T.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 187 - 208
  • [8] Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients From 2003-2011
    Agarwal, Shikhar
    Sud, Karan
    Shishehbor, Mehdi H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (16) : 1901 - 1913
  • [9] Development of administrative data algorithms to identify patients with critical limb ischemia
    Bekwelem, Wobo
    Bengtson, Lindsay G. S.
    Oldenburg, Niki C.
    Winden, Tamara J.
    Keo, Hong H.
    Hirsch, Alan T.
    Duval, Sue
    VASCULAR MEDICINE, 2014, 19 (06) : 483 - 490
  • [10] Critical Limb Ischemia
    Elsayed, Sarah
    Clavijo, Leonardo C.
    CARDIOLOGY CLINICS, 2015, 33 (01) : 37 - +